150 related articles for article (PubMed ID: 26231802)
1. MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting.
Shi M; Spurgeon S; Press R; Olson S; Fan G
Ann Hematol; 2015 Nov; 94(11):1941-4. PubMed ID: 26231802
[No Abstract] [Full Text] [Related]
2. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
Hamadeh F; MacNamara SP; Aguilera NS; Swerdlow SH; Cook JR
Mod Pathol; 2015 Apr; 28(4):564-74. PubMed ID: 25216226
[TBL] [Abstract][Full Text] [Related]
3. VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
Mizuta S; Yamane N; Mononobe S; Watanabe A; Matsuki S; Komai T; Koba Y; Mitani S; Kawata T; Tamekane A; Watanabe M
Cytometry B Clin Cytom; 2022 Jan; 102(1):50-61. PubMed ID: 33682304
[TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
[TBL] [Abstract][Full Text] [Related]
5. IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.
Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Minervini CF; Brunetti C; Impera L; Ricco A; Cellamare A; Specchia G; Albano F
Ann Hematol; 2014 Sep; 93(9):1605-7. PubMed ID: 24408161
[No Abstract] [Full Text] [Related]
6. MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart.
Patkar N; Subramanian PG; Deshpande P; Ghodke K; Tembhare P; Mascarenhas R; Muranjan A; Chaudhary S; Bagal B; Gujral S; Sengar M; Menon H
Leuk Lymphoma; 2015 Feb; 56(2):420-5. PubMed ID: 24828863
[TBL] [Abstract][Full Text] [Related]
7. Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.
Baloda V; Wheeler SE; Murray DL; Kohlhagen MC; Vos JA; Yatsenko SA; Agha ME; Djokic M; Swerdlow SH; Bailey NG
Diagn Pathol; 2022 Aug; 17(1):63. PubMed ID: 35932039
[TBL] [Abstract][Full Text] [Related]
8. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT
Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639
[TBL] [Abstract][Full Text] [Related]
9. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: one disease or three?
Kraus MD
Am J Clin Pathol; 2001 Dec; 116(6):799-801. PubMed ID: 11764065
[No Abstract] [Full Text] [Related]
10. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
[TBL] [Abstract][Full Text] [Related]
11. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with inv(16)(p13q22) as a sole genetic abnormality.
Frater JL; Mirkhaef M; Batanian JR
Cancer Genet Cytogenet; 2007 Apr; 174(2):161-5. PubMed ID: 17452259
[TBL] [Abstract][Full Text] [Related]
12. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.
Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228
[TBL] [Abstract][Full Text] [Related]
13. Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.
Oishi N; Inoue T; Odate T; Mochizuki K; Ohashi K; Kirito K; Kondo T
Pathol Int; 2020 Jul; 70(7):458-462. PubMed ID: 32323419
[TBL] [Abstract][Full Text] [Related]
14. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
Manasanch EE; Braylan R; Stetler-Stevenson M; Yuan C; Gounden V; Korde N; Tageja N; Bhutani M; Calvo K; Maric I; Roschewski M; Staudt LM; Landgren O
Leuk Lymphoma; 2014 Jun; 55(6):1402-3. PubMed ID: 23915224
[No Abstract] [Full Text] [Related]
15. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with Hodgkin disease. A report of two cases.
Rosales CM; Lin P; Mansoor A; Bueso-Ramos C; Medeiros LJ
Am J Clin Pathol; 2001 Jul; 116(1):34-40. PubMed ID: 11447749
[TBL] [Abstract][Full Text] [Related]
16. Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysis.
Martino G; Marra A; Ascani S; Sportoletti P
Ann Hematol; 2019 Jun; 98(6):1507-1508. PubMed ID: 30426157
[No Abstract] [Full Text] [Related]
17. Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Chakraborty R; Kapoor P; Ansell SM; Gertz MA
Expert Rev Anticancer Ther; 2015; 15(10):1143-56. PubMed ID: 26196236
[TBL] [Abstract][Full Text] [Related]
18. Lymphoplasmacytic Lymphoma Presenting with Diarrhea and Joint Pain Which was Successfully Diagnosed by an MYD88 Mutation Analysis.
Fukushima M; Okoshi Y; Fukazawa K; Koshino M; Ishiguro S; Mitsuhashi S; Saitoh H; Iijima T; Kojima H; Hori M
Intern Med; 2017; 56(7):847-851. PubMed ID: 28381754
[TBL] [Abstract][Full Text] [Related]
19. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.
Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JK; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E
Virchows Arch; 2016 Mar; 468(3):259-75. PubMed ID: 26454445
[TBL] [Abstract][Full Text] [Related]
20. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia].
Timár B
Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
